Paul A. "Tony" DeCarolis, MD


Medical Oncologist / Hematologist

Colorado Springs Style Magazine Top Doc 2017
Colorado Springs Style Magazine Top Doc 2019
Colorado Springs Style Magazine Top Doc 2020
Colorado Springs Style Magazine Top Doc 2022
Paul A.

Colorado Springs - Penrose Pavilion

2312 N. Nevada Ave., Ste. 400
Colorado Springs, CO 80907

719-577-2555

Request an Appointment

About Paul A. "Tony" DeCarolis, MD

Dr. Tony DeCarolis is a board-certified medical oncologist and hematologist. He has spent over 20 years supporting and building the community-based cancer care in Colorado Springs. Dr. DeCarolis has a strong interest in blood cancers, including Hodgkin’s and Non-Hodgkin’s Lymphoma and Multiple Myeloma. A collaborative approach to care is important to Dr. DeCarolis’ practice strategy. He is active on tumor boards, working closely with pathologists, radiologists, surgeons, radiation oncologists, and other subspecialties. In presenting and consulting on cancer cases, Dr. DeCarolis can ensure his patients have the benefit of shared knowledge from multiple cancer experts when planning their cancer treatment options. He has a true passion for treating his patients with compassion and understanding and strives to provide them with evidence-based, cutting-edge treatment options.

Advanced Practice Providers Working With Dr. DeCarolis

Board Certifications

Hematology
Internal Medicine
Medical Oncology

Specialties

  • Bone Cancer
  • Blood Cancers
    • Hodgkin’s Lymphoma
    • Lymphoma
    • Multiple Myeloma
    • Non-Hodgkin’s Lymphoma

Education

Fellowship

Hematology & Oncology, University of Kansas Medical Center, Kansas, KS

Residency

Internal Medicine, University of Kansas Medical Center, Kansas City, KS

Medical School

Internal Medicine, University of Kansas Medical Center, Kansas City, KS

 
 

Additional Information

American College of Physicians
American Society of Clinical Oncology
American Society of Hematology
El Paso County Medical Society
Penrose Hospital Cancer Committee, Chairman
US Oncology Network Pharmacy & Therapeutics Committee